Transplant recipients on the edge of the hypocalcemia abyss.
Hypovitaminosis D is a risk factor for transplant-related osteoporosis. Its contribution to severe hypocalcemia in transplant recipients is less well recognized. We present 2 cases to illustrate how risk factors specific to transplant recipients significantly increase the risk of development of severe hypocalcemia, on a background of unrecognized vitamin D deficiency. Regular surveillance of calcium homeostasis should be incorporated into routine clinical care of transplant recipients.
Lee
Paul
P
Department of Endocrinology, St Vincent's Hospital, New South Wales, Australia. p.lee@garvan.org.au
Samaras
Katherine
K
Glanville
Allan R
AR
Center
Jacqueline R
JR
D002117:Calcitriol / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D002762:Cholecalciferol / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000601:surgery*; D006801:Humans; D006996:Hypocalcemia / Q000150:complications* / Q000209:etiology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects*; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000150:complications / Q000601:surgery*; D012016:Reference Values; D016896:Treatment Outcome; D014807:Vitamin D / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000150:complications
D007166:Immunosuppressive Agents; D014807:Vitamin D; D002762:Cholecalciferol; D002117:Calcitriol; D008274:Magnesium; D002118:Calcium